Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alexander Ching

Orthopaedic Surgery Tualatin, OR Medical Doctor

NPI 1932263845 CMS profile 133605

19255 Sw 65Th Ave Ste 220, Tualatin, OR 97062

Open in the dashboard

General payments

$43,779

123 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alexander Ching of Tualatin, OR is reported in the CMS Open Payments database as having received $43,779 across 123 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,037 23
2024 General $2,488 20
2023 General $2,716 28
2022 General $368 3
2021 General $97 3
2020 General $6,591 10
2019 General $30,482 36

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alexander Ching
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Alexander Ching were reported at $1,037. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Alexander Ching Orthopaedic Surgery median Middle half National median
2019 $30,482 $644 $140–$2,844 $163
2020 $6,591 $312 $75–$1,860 $114
2021 $97 $520 $117–$2,495 $132
2022 $368 $598 $128–$2,731 $149
2023 $2,716 $461 $128–$2,264 $160
2024 $2,488 $497 $134–$2,475 $164
2025 $1,037 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $22,195 21 payments
  2. Medical Device Business Services, Inc. $10,375 15 payments
  3. NuVasive, Inc. $3,012 12 payments
  4. Aesculap, Inc. $2,601 2 payments
  5. Providence Medical Technology, Inc. $1,589 36 payments
  6. Abbott Laboratories $978 10 payments
  7. Ethicon Inc. $878 1 payment
  8. Alphatec Spine, Inc $677 3 payments
  9. DePuy Synthes Products, Inc. $524 1 payment
  10. Zimvie Inc. $252 1 payment
  11. Other $700 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $19,125 4 payments
  2. Consulting Fee $11,466 5 payments
  3. Travel and Lodging $6,565 28 payments
  4. Food and Beverage $3,771 83 payments
  5. Gift $2,601 2 payments
  6. Education $252 1 payment
Products named General payments · program years 2019–2025
  1. CREO MIS $10,430 5 payments
  2. CREO $10,180 7 payments
  3. VIPER $7,723 4 payments
  4. EXPEDIUM $4,192 6 payments
  5. CONDUIT $2,925 1 payment
  6. BRAINLAB $2,925 1 payment
  7. XLIF $2,400 1 payment
  8. ALIF $2,400 1 payment
  9. SYNAPSE $1,267 5 payments
  10. ExcelsiusGPS Robotic Navigation System $1,137 5 payments
  11. Other $6,852 64 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

229

Median for Orthopedic Surgery: 203

Drug cost

$3,200

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methocarbamol Generic 71 $1,246
Oxycodone Hcl Generic 60 $1,124
Tramadol Hcl Generic 56 $406
Baclofen Generic 24 $238
Gabapentin Generic 18 $186

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 46 billing codes

Paid by Medicare

$172,430

Medicare's payments for the services billed

Medicare patients

217

Average age 75

Services billed

581

130 women, 87 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 68%
Ischemic heart disease 22%
Depression 22%
Osteoporosis 19%
Diabetes 18%
Chronic kidney disease 17%
Atrial fibrillation 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

123 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Oregon

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record